MAN & Science SA
7.6 FTEThe score of MAN & Science shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -81 % Total assets -62 % Headcount (avg FTE) +49 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MAN & Science's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 10 Oct 2025
- Year ended 31 Dec 2023filed on 31 Jan 2025
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 06 May 2022
MAN & Science's financial analysis
- Solvency45.2%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MAN & Science
MAN & Science's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0837.403.770
- VAT number
- BE0837403770
- Peppol
- Registered · 0208:0837403770 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 29 Jun 2011
- Registered office
- 4000 Liège
- Size
- Micro · 7.6 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Manufacture of medical and dental instruments and supplies (NACE 32500)
MAN & Science (SA) has been based in Liège since 2011, active in: manufacture of medical and dental instruments and supplies. For 2025, it reports a net loss of €3.34m and equity of €2.44m; its revenue is not published. With 7.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 45.2%, below the median of its sector (46.9%).
Companies similar to MAN & Science
Companies in the same business, of comparable size and area, outside its group.
- Euromi Manufacture of medical and dental instruments and supplies Dison · balance sheet €5.14m
- Sprotech Manufacture of medical and dental instruments and supplies Sint-Niklaas · balance sheet €3.36m
- Spentys Manufacture of medical and dental instruments and supplies Forest · balance sheet €3.99m
- Matton Orthopedie Manufacture of medical and dental instruments and supplies Bruges · balance sheet €5.52m
- Optimal Control Manufacture of medical and dental instruments and supplies Diest · balance sheet €3.17m
- Hippocreates Manufacture of medical and dental instruments and supplies Hasselt · balance sheet €2.01m
- SOS Oxygene Benelux Wholesale of pharmaceutical and medical goods Nivelles · balance sheet €4.91m
- Laboratoria Bota Manufacture of pharmaceutical preparations Deinze · balance sheet €3.62m
Frequently asked questions about MAN & Science
What is the revenue of MAN & Science?
MAN & Science files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MAN & Science?
In Belgium, the VAT number is the company number prefixed with BE: BE0837403770 for MAN & Science, if the company is VAT-registered. Its company number (CBE) is 0837.403.770.
Where is the registered office of MAN & Science?
According to the CBE register, the registered office of MAN & Science is in 4000 Liège.
What is the equity of MAN & Science?
At the close of the 2025 financial year, the equity of MAN & Science amounts to 2,438,561 €, a solvency of 45.2% of total assets.
How many people work at MAN & Science?
7.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages MAN & Science?
The register lists 7 active mandates at MAN & Science. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MAN & Science
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →